Post-Theranos, Startups Are Still Out for Blood

‘Hubris is very dangerous’: How blood diagnostic companies are distancing themselves from Theranos’ fraud charges

Erin Schumaker
OneZero
Published in
5 min readApr 18, 2019

--

Illustration: Ariel Davis

TTanay Tandon ditched class the day Elizabeth Holmes came to speak to his fellow freshmen at Stanford University a few years ago. At the time, says Tandon, now 22, the campus community was already…

--

--